Literature DB >> 23053245

Spatially controlled photothermal heating of bladder tissue through single-walled carbon nanohorns delivered with a fiberoptic microneedle device.

R Lyle Hood1, William F Carswell, Amanda Rodgers, Mehmet A Kosoglu, Marissa Nichole Rylander, David Grant, John L Robertson, Christopher G Rylander.   

Abstract

Laser-based photothermal therapies for urothelial cell carcinoma (UCC) are limited to thermal ablation of superficial tumors, as treatment of invasive lesions is hampered by shallow light penetration in bladder tissue at commonly used therapeutic wavelengths. This study evaluates the utilization of sharp, silica, fiberoptic microneedle devices (FMDs) to deliver single-walled carbon nanohorns (SWNHs) serving as exogenous chromophores in conjunction with a 1,064-nm laser to amplify thermal treatment doses in a spatially controlled manner. Experiments were conducted to determine the lateral and depth dispersal of SWNHs in aqueous solution (0.05 mg/mL) infused through FMDs into the wall of healthy, inflated, ex vivo porcine bladders. SWNH-perfused bladder regions were irradiated with a free-space, CW, 1,064-nm laser in order to determine the SWNH efficacy as exogenous chromophores within the organ. SWNHs infused at a rate of 50 μL/min resulted in an average lateral expansion rate of 0.36 ± 0.08 cm(2)/min. Infused SWNHs dispersal depth was limited to the urothelium and muscular propria for 50 μL/min infusions of 10 min or less, but dispersed through the entire thickness after a 15-min infusion period. Irradiation of SWNH-perfused bladder tissue with 1,064 nm laser light at 0.95 W/cm(2) over 40 s exhibited a maximum increase of approximately 19 °C compared with an increase of approximately 3 °C in a non-perfused control. The results indicate that these silica FMDs can successfully penetrate into the bladder wall to rapidly distribute SWNHs with some degree of lateral and depth control and that SWNHs may be a viable exogenous chromophore for photothermal amplification of laser-based UCC treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053245     DOI: 10.1007/s10103-012-1202-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  29 in total

Review 1.  A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology.

Authors:  I Larizgoitia; J M Pons
Journal:  BJU Int       Date:  1999-07       Impact factor: 5.588

2.  Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics.

Authors:  P F Morrison; M Y Chen; R S Chadwick; R R Lonser; E H Oldfield
Journal:  Am J Physiol       Date:  1999-10

3.  Holmium laser resection of bladder tumors (HoLRBT).

Authors:  A Das; P Gilling; M Fraundorfer
Journal:  Tech Urol       Date:  1998-03

4.  Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience.

Authors:  H A Syed; C S Biyani; N Bryan; S J Brough; C S Powell
Journal:  J Endourol       Date:  2001-08       Impact factor: 2.942

Review 5.  Current management of invasive and metastatic transitional cell carcinoma of the bladder.

Authors:  J B Thrasher; E D Crawford
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

6.  Potential for therapy of drugs and hyperthermia.

Authors:  G M Hahn
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

7.  Stereotactically guided laser therapy of occult breast tumors: work-in-progress report.

Authors:  K Dowlatshahi; M Fan; V E Gould; K J Bloom; A Ali
Journal:  Arch Surg       Date:  2000-11

8.  Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch.

Authors:  S Hart; E C Skinner; B E Meyerowitz; S Boyd; G Lieskovsky; D G Skinner
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

9.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

10.  Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C.

Authors:  Jorge Soler-Martínez; Raúl Vozmediano-Chicharro; Pedro Morales-Jiménez; David Hernández-Alcaraz; Eloy Vivas-Vargas; Ildefonso Santos García-Vaquero; Víctor Baena-González
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

View more
  4 in total

1.  Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugates.

Authors:  Matthew R DeWitt; Allison M Pekkanen; John Robertson; Christopher G Rylander; Marissa Nichole Rylander
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

2.  3D viability imaging of tumor phantoms treated with single-walled carbon nanohorns and photothermal therapy.

Authors:  Jon Whitney; Matthew DeWitt; Bryce M Whited; William Carswell; Alex Simon; Christopher G Rylander; Marissa Nichole Rylander
Journal:  Nanotechnology       Date:  2013-06-18       Impact factor: 3.874

3.  A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.

Authors:  J W Van Hattum; E M Scutigliani; R F C P A Helderman; R Zweije; H M Rodermond; A L Oei; J Crezee; J R Oddens; T M De Reijke; P M Krawczyk
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

4.  Assessment and Modeling of Plasmonic Photothermal Therapy Delivered via a Fiberoptic Microneedle Device Ex Vivo.

Authors:  Forhad Akhter; Santiago Manrique-Bedoya; Chris Moreau; Andrea Lynn Smith; Yusheng Feng; Kathryn M Mayer; R Lyle Hood
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.